OP 17. Perfluorohexyloctane For Long-Term Storage In Rat Pancreas Transplant Model


T. Marada, K. Zacharovova, I. Brabcova, E. Vodrazkova

Chair(s): László Kóbori, Thomas van Gulik & Dávid Ágoston Kovács

12:40 - 12:50h at Pest Room (C)

Categories: Organ and Cell Transplantation, Oral Session

Session: Oral Sesion II - Organ and Cell Transplantation


Background:
Perfluorohexyloctane is a promising storage solution, it has been successfully used for pancreas preservation for islet isolation. This hyperoxygen carrier has been designed to prevent the pancreas graft ischemia cold-storage injury. In our study we aimed to evaluate its impact on whole organ storage in rat pancreas transplantation model.

Material and Methods:
Brown-Norway rats were used for syngeneic heterotopic pancreas transplantation. Procured organs were cold-stored for 18 hours in preoxygenated perfluorohexyloctane (PFH) (n=8), in University of Wisconsin solution (UW) (n=8), or transplanted immediately in control group (n=8). Two hours after reperfusion we took blood and pancreas tissue samples for biochemistry and gene analysis (real-time PCR).

Result:
Significant difference between UW and PFH group was observed in TNF-beta and endotelin 1 gene, which was twofold over-expressed in UW group. Blood samples in UW group compared to PFH group showed higher levels of lipase and amylase (5,5±2,8 vs 3±0,7 ukat/l resp. 94,2±25,2 vs 67,7±13,4 ukat/l, p<0,05).

Conclusion:
We found significantly lower expression of endotelin 1 and TNF-beta gene and lower concentrations of amylase and lipase in PFH group. All these findings demonstrate lower rate of ischemia-reperfusion injury in PFH group. These findings may cause better post-transplant outcomes after long-term cold-storage in perfluorohexyloctane compared to UW solution. Further research on this field is required.